Dynavax Technologies | Ativo Circulante

Current Assets Alterar Data
AbbVie USD 38.87B 5.65B 2024-03
Adma Biologics USD 276.42M 19.41M 2024-03
Amgen USD 28.03B 2.3B 2024-03
AstraZeneca USD 25.59B 540M 2024-03
Biogen USD 6.76B 103.1M 2024-03
BioMarin Pharmaceutical USD 2.99B 28.92M 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Dynavax Technologies USD 851.29M 7.83M 2024-03
Gilead Sciences USD 14.04B 2.41B 2024-03
Glaxosmithkline GBP 17.21B 1.44B 2024-03
Merck USD 31.44B 509M 2024-03
Neurocrine Biosciences USD 1.8B 149.1M 2024-03
Novartis USD 26.45B 4.03B 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Regeneron Pharmaceuticals USD 18.87B 5.62B 2024-03
Roche Holding CHF 33.45B 2.47B 2023-12
Sarepta Therapeutics USD 2.46B 14.02M 2024-03
TG Therapeutics USD 360.58M 41.47M 2024-03
Vertex Pharmaceuticals USD 13.29B 1.41B 2024-03



Dynavax Technologies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.